Pronóstico del mercado de organizaciones de ventas por contrato farmacéutico de Oriente Medio y África hasta 2030 – Análisis regional – por servicios (servicios comerciales y servicios no comerciales), módulos (módulos sindicados y módulos dedicados), área terapéutica (trastornos cardiovasculares, oncología, trastornos metabólicos, neurología, Enfermedades Ortopédicas, Enfermedades Infecciosas y Otras), y Usuario Final (Empresas Biofarmacéuticas y Empresas Farmacéuticas)
Expansión en Los mercados emergentes impulsan el mercado de organizaciones de ventas por contrato farmacéuticas (CSO) en Oriente Medio y África La trayectoria futura del mercado de organizaciones de ventas por contrato farmacéuticas (CSO) está marcada claramente por la tendencia estratégica de expandirse a los mercados emergentes. A medida que aumenta el panorama farmacéutico mundial, las economías emergentes ganan protagonismo y las OSC reconocen cada vez más el potencial sin explotar. Los mercados emergentes presentan oportunidades impulsadas por una mayor conciencia sobre la atención sanitaria, la expansión de las poblaciones de clase media y el aumento de las inversiones gubernamentales en infraestructura sanitaria. Al ampliar sus operaciones a estos mercados florecientes, las OSC pueden capitalizar la creciente demanda de productos farmacéuticos y establecer una posición sólida desde el principio en mercados preparados para un crecimiento sustancial. Sin embargo, esta expansión requiere una comprensión inteligente de los panoramas regulatorios locales, los matices culturales y los diversos sistemas de salud. La expansión exitosa a los mercados emergentes exige un enfoque personalizado, donde las OSC deben alinear sus estrategias con los desafíos y oportunidades únicos de cada región. Además, dichas expansiones posicionan a las OSC como actores cruciales en el ecosistema de atención médica global, contribuyendo al crecimiento de los ingresos y al objetivo más amplio de mejorar la accesibilidad y los resultados de la atención médica en estos mercados en evolución. En esencia, el movimiento estratégico hacia la expansión en los mercados emergentes surge como una tendencia con visión de futuro, que refleja la adaptabilidad y previsión de las OSC farmacéuticas al navegar las complejidades de un panorama farmacéutico globalizado.
Visión general del mercado de organizaciones de ventas por contrato farmacéuticas en Oriente Medio y África
El mercado de organizaciones de ventas por contrato farmacéuticas en Oriente Medio y África está segmentado en Arabia Saudita, Sudáfrica, los Emiratos Árabes Unidos y el resto de MEA. Los factores que impulsan el crecimiento del mercado incluyen la creciente integración de las tecnologías digitales y el creciente interés de las empresas farmacéuticas por aumentar las ventas de productos. Sin embargo, los problemas de calidad asociados con la subcontratación obstaculizan el crecimiento del mercado. Los Emiratos Árabes Unidos son un país desarrollado de la región y su sector sanitario ha mostrado un crecimiento notable debido principalmente al aumento de la población y al aumento de la demanda de productos farmacéuticos. El progresivo sector de la salud ofrece oportunidades de crecimiento vitales para la industria farmacéutica. Los Emiratos Árabes Unidos tienen una de las industrias farmacéuticas de más rápido crecimiento del mundo, que también es conocida por adoptar tecnologías avanzadas. Iniciativas como la Estrategia Industrial de Dubai 2030 y la Visión 2030 de Abu Dhabi se centran en desarrollar el sector farmacéutico del país considerando las perspectivas de crecimiento futuro, el potencial de exportación y el impacto económico a mediano y largo plazo. Los importantes avances en la investigación científica favorecen el desarrollo y la producción de fármacos con potencial innovador. La feroz competencia en la industria farmacéutica obliga a las empresas a llevar sus productos terapéuticos al mercado lo antes posible para mantenerse en la cima del mercado. Por lo tanto, la creciente demanda de productos farmacéuticos eficientes, un número cada vez mayor de compañías farmacéuticas, la creciente incidencia de enfermedades infecciosas y crónicas y los frecuentes lanzamientos de productos respaldan el progreso de la industria farmacéutica en Medio Oriente y África, lo que requiere el uso de servicios de CSO. lo que favorece el crecimiento del mercado de organizaciones de venta por contrato farmacéutico en la región.
Ingresos del mercado de organizaciones de ventas por contrato farmacéutico de Oriente Medio y África y pronóstico hasta 2030 (millones de dólares estadounidenses)
Segmentación del mercado de organizaciones de ventas por contrato farmacéutico de Oriente Medio y África
El mercado de organizaciones de ventas por contrato farmacéutico de Oriente Medio y África está segmentado en servicios, módulos, área terapéutica, usuario final y país.
Basado en los servicios, el mercado de organizaciones de ventas por contrato de productos farmacéuticos de Oriente Medio y África se bifurca en servicios comerciales y servicios no comerciales. El segmento de servicios comerciales tuvo una mayor participación del mercado de organizaciones de ventas por contrato farmacéuticas de Oriente Medio y África en 2022.
Basado en módulos, el mercado de organizaciones de ventas por contrato farmacéuticas de Oriente Medio y África se bifurca en módulos sindicados y módulos dedicados. El segmento de módulos sindicados tuvo una mayor participación en el mercado de organizaciones de ventas por contrato de productos farmacéuticos de Oriente Medio y África en 2022.
Según el área terapéutica, el mercado de organizaciones de ventas por contrato de productos farmacéuticos de Oriente Medio y África está segmentado en trastornos cardiovasculares, oncología y trastornos metabólicos. , neurología, enfermedades ortopédicas, enfermedades infecciosas y otras. El segmento de oncología tuvo la mayor participación del mercado de organizaciones de ventas por contrato farmacéuticas de Oriente Medio y África en 2022.
Según el usuario final, el mercado de organizaciones de ventas por contrato farmacéuticas de Oriente Medio y África se bifurca en empresas biofarmacéuticas y empresas farmacéuticas. El segmento de empresas farmacéuticas tuvo una mayor participación en el mercado de organizaciones de ventas por contrato de productos farmacéuticos de Oriente Medio y África en 2022.
Según el país, el mercado de organizaciones de ventas por contrato de productos farmacéuticos de Oriente Medio y África está segmentado en Arabia Saudita, Sudáfrica y los Emiratos Árabes Unidos. y el resto de Oriente Medio y África. Arabia Saudita dominó el mercado de organizaciones de ventas por contrato de productos farmacéuticos en Oriente Medio y África en 2022.
Aenova Holding GmbH, IQVIA Holdings Inc, Pfizer Inc y Syneos Health Inc son algunas de las empresas líderes que operan en las ventas por contrato de productos farmacéuticos en Oriente Medio y África. mercado de organizaciones.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa PEST Analysis
5. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Integration of Digital Technologies
5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
5.2 Key Market Restraints
5.2.1 Quality Issues Associated with Outsourcing
5.3 Key Market Opportunities
5.3.1 Rising Use of Telemedicine and Remote Detailing
5.4 Key Future Trends
5.4.1 Expansion in Emerging Markets
5.5 Impact Analysis:
6. Pharmaceutical Contract Sales Organizations Market - Middle East & Africa Analysis
6.1 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
7. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services
7.1 Overview
7.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
7.3 Commercial Services
7.3.1 Overview
7.3.2 Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Commercial Services
7.4.1 Overview
7.4.2 Non-Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules
8.1 Overview
8.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
8.3 Syndicated Modules
8.3.1 Overview
8.3.2 Syndicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Dedicated Modules
8.4.1 Overview
8.4.2 Dedicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area
9.1 Overview
9.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
9.3 Cardiovascular Disorders
9.3.1 Overview
9.3.2 Cardiovascular Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Metabolic Disorders
9.5.1 Overview
9.5.2 Metabolic Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Neurology
9.6.1 Overview
9.6.2 Neurology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Orthopaedic Diseases
9.7.1 Overview
9.7.2 Orthopedic Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Infectious Diseases
9.8.1 Overview
9.8.2 Infectious Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User
10.1 Overview
10.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Biopharmaceutical Companies
10.3.1 Overview
10.3.2 Biopharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Country Analysis
11.1 Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Country
11.1.1 Saudi Arabia
11.1.1.1 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.3 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.4 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.5 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.2 UAE
11.1.2.1 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.2 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.2.3 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.2.4 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.2.5 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.3 South Africa
11.1.3.1 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3.2 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.3.3 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.3.4 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.3.5 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.4 Rest of Middle East & Africa
11.1.4.1 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.4.2 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.4.3 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.4.4 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.4.5 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview
13. Company Profiles
13.1 IQVIA Holdings Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Syneos Health Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Aenova Holding GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Pfizer Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
?
List of Tables
Table 1. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Segmentation
Table 2. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 3. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 4. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 5. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 6. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 7. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 8. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 9. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 10. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 11. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 12. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 13. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
Table 19. Glossary of Terms, Middle East & Africa Pharmaceutical Contract Sales Organizations Market
?
List of Figures
Figure 1. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
Figure 2. Middle East & Africa - PEST Analysis
Figure 3. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
Figure 6. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
Figure 7. Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Non-Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
Figure 10. Syndicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Dedicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
Figure 13. Cardiovascular Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Oncology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Metabolic Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Neurology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Orthopedic Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 21. Biopharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 24. Middle East & Africa Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
Figure 25. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
1. Aenova Holding GmbH
2. IQVIA Holdings Inc
3. Pfizer Inc
4. Syneos Health Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Pharmaceutical Contract Sales Organizations Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.